{"id":18091,"date":"2023-06-15T11:51:51","date_gmt":"2023-06-15T09:51:51","guid":{"rendered":"https:\/\/www.pharmaforum.be\/news\/spin-off-sandoz\/"},"modified":"2023-07-11T14:58:30","modified_gmt":"2023-07-11T12:58:30","slug":"spin-off-sandoz","status":"publish","type":"news","link":"https:\/\/www.pharmaforum.be\/fr\/news\/spin-off-sandoz\/","title":{"rendered":"Spin-off Sandoz"},"content":{"rendered":"<p>Le Groupe Novartis a annonc\u00e9 son intention de se s\u00e9parer des activit\u00e9s de Sandoz en cr\u00e9ant une nouvelle soci\u00e9t\u00e9 ind\u00e9pendante \u00e0 100%, cot\u00e9e \u00e0 la bourse de Zurich.<\/p>\n<p>Pour Sandoz, il s&#8217;agit de continuer \u00e0 investir fortement dans les m\u00e9dicaments g\u00e9n\u00e9riques, biosimilaires et antibiotiques, pour \u00e0 la fois :<\/p>\n<p>\u2022 renforcer sa position de n\u00b01 en Europe pour les m\u00e9dicaments g\u00e9n\u00e9riques et biosimilaires.<br \/>\n\u2022 se concentrer enti\u00e8rement sur son ambition de devenir le laboratoire num\u00e9ro 1 mondial dans le domaine des m\u00e9dicaments g\u00e9n\u00e9riques et biosimilaires.<\/p>\n<p>Si vous souhaitez en savoir plus, n\u2019h\u00e9sitez pas \u00e0 contacter votre repr\u00e9sentant Sandoz ou surfez sur https:\/\/www.sandoz.com\/sandoz-spin.<\/p>\n<p>2023-MDB-016 \u2013 289048 \u2013 Valid until 06\/2025<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le Groupe Novartis a annonc\u00e9 son intention de se s\u00e9parer des activit\u00e9s de Sandoz en cr\u00e9ant une nouvelle soci\u00e9t\u00e9 ind\u00e9pendante \u00e0 100%, cot\u00e9e \u00e0 la bourse de Zurich.<\/p>\n","protected":false},"featured_media":0,"template":"","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_api_id":"47172","_exhibitors":["17164"],"footnotes":""},"edition":[451],"country":[],"class_list":["post-18091","news","type-news","status-publish","hentry","edition-pharma-forum-2023"],"_links":{"self":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/18091","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/types\/news"}],"version-history":[{"count":3,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/18091\/revisions"}],"predecessor-version":[{"id":18099,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/news\/18091\/revisions\/18099"}],"wp:attachment":[{"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/media?parent=18091"}],"wp:term":[{"taxonomy":"edition","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/edition?post=18091"},{"taxonomy":"country","embeddable":true,"href":"https:\/\/www.pharmaforum.be\/fr\/wp-json\/wp\/v2\/country?post=18091"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}